Alteration in enzymatic function of human cytochrome P450 by silver nanoparticles

Research Journal of Environmental Toxicology

Volumn 5, Issue 1, 2011, Pages 58-64

  Warisnoicharoen, W ^a   Hongpiticharoen, P ^a   Lawanprasert, S ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Biotransformation; Cytochrome P45O; Metabolism; Nanotechnology; Silver nanoparticles

Indexed keywords

CYTOCHROME P450; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; SILVER NANOPARTICLE;

ARTICLE; AWARENESS; BIOSYNTHESIS; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME METABOLISM; IC 50; IN VITRO STUDY; PARTICLE SIZE; PHYSICAL CHEMISTRY; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 78649725637     PISSN: 18193420     EISSN: None     Source Type: Journal    
DOI: 10.3923/rjet.2011.58.64     Document Type: Article

References (24)

1. Aillon, K.L., Y. Xie, N. El-Gendy, C.J. Berkland and M.L. Forrest, 2009. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev., 61: 457-466.
2. Bar-llan, O., R.M. Albrecht, V.E. Fako and D.Y. Furgeson, 2009. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small, 16: 1897-1910.
3. Chung, Y.C., I.H. Chen and C.J. Chen, 2008. The surface modification of silver nanoparticles by phosphoryl disulfides for improved biocompatibility and intracellular uptake. Biomaterials, 29: 1807-1816.
4. Cohen, L.H, M.J. Remley, D. Raunig and A.D.N. Vaz, 2003. In vitro drug interactions of cytochrome p450: An evaluation of fluorogenic to conventional substrates. Drug Metab. Dispos., 31: 1005-1015.
5. Coleman, M.D., 2005. Human Drug Metabolism. 1st Edn., John Wiley and Sons, Chichester, ISBN-13 978-0-470-86353-6.
6. Elechiguerra, J.L., J.L. Burt, J.R. Morones, A. Camacho-Bragado, X. Gao, H.H. Lara and M.J. Yacaman, 2005. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol., 3: 6-6.
7. Foged, C., B. Brodin, S. Frokjaer and A. Sundblad, 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm., 298: 315-322.
8. Glue, P. and R.P. Clement, 1999. Cytochrome P450 enzymes and drug metabolism- basic concepts and methods of assessment. Cell. Mol. Neurobiol., 19: 309-323.
9. Goodman, C.M., C.D. McCusker, T. Yilmaz and V.M. Rotello, 2004. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem., 15: 897-900.
10. Goshman, L., J. Fish and K. Roller, 1999. Clinically significant cytochrome P450 drug interactions. J. Pharm. Soc. Wisconsin., 1999: 23-38.
11. Guengerich, F.P., 2008. Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol, 21: 70-83.
12. Kim, J.S., E. Kuk, K.N. Yu, J.H. Kim and S.J. Park et al., 2007. Antimicrobial effects of silver nanoparticles. Nanomed. Nanotechnol. Biol. Med., 3: 95-101.
13. Link, S. and M.A. El-Sayed, 1999. Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J. Phys. Chem. B, 103: 8410-8426.
14. Marambio-Jones, C. and E.M.V. Hoek, 2010. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J. Nanopart. Res., 12: 1531-1551.
15. Maria, L.C.S., A.L.C. Santos, P.C. Oliveira, A.S.S. Valle, H.S. Barud, Y. Messaddeq and S.J.L. Ribeiro, 2010. Preparation and antibacterial activity of silver nanoparticles impregnated in bacterial cellulose. Polímeros, 20: 72-77.
16. Miller, C.R., B. Bondurant, S.D. McLean, K.A. McGovern and D.F. O'Brien, 1998. Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry, 37: 12875-12883.
17. Navarro, E., F. Piccapietra, B. Wagner, F. Marconi and R. Kaegi et al., 2008. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol., 42: 8959-8964.
18. Osaka, T., T. Nakanishi, S. Shanmugam, S. Takahama and H. Zhang, 2009. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloids Surf. B, 71: 325-330.
19. Sereemaspun, A., P. Hongpiticharoen, R. Rojanathanes, P. Maneewattanapinyo, S. Ekgasit and W. Warisnoicharoen, 2008. Inhibition of human cytochrome P45O enzymes by metallic nanoparticles: A preliminary to nanogenomics. Int. J. Pharmacol., 4: 492-495.
20. Solomon, S.D., M. Bahadory, A.V. Jeyarajasingam, S.A. Rutkowsky and C. Boritz, 2007. Synthesis and study of silver nanoparticles. J. Chem. Educ., 84: 322-325.
21. Sondi, I. and B. Salopek-Sondi, 2004. Silver nanoparticles as antimicrobial agent: Case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci., 275: 177-182.
22. Song, K.C., S.M. Lee, T.S. Park and B.S. Lee, 2009. Preparation of colloidal silver nanoparticles by chemical reduction method. Korean J. Chem. Eng., 26: 153-155.
23. Yoksan, R. and S. Chirachanchai, 2010. Silver nanoparticle-loaded chitos an-starch based films: Fabrication and evaluation of tensile, barrier and antimicrobial properties. Mater. Sci. Eng. C, 30: 891-897.
24. Zou, L., M.R. Harkey and G.L. Henderson, 2002. Effects of herbal components on cDNA-expressed cytochrome P45O enzyme catalytic activity. Life Sci., 71: 1579-1589.